No photo of Phillip H Kuo

View Scopus Profile

Phillip H Kuo

  • 1250 Citations
  • 13 h-Index
19952019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Phillip H Kuo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Fluorodeoxyglucose F18 Medicine & Life Sciences
Nephrogenic Fibrosing Dermopathy Medicine & Life Sciences
Dopamine Plasma Membrane Transport Proteins Medicine & Life Sciences
Single-Photon Emission-Computed Tomography Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Gadolinium Medicine & Life Sciences
Corpus Striatum Medicine & Life Sciences
Radiopharmaceuticals Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 1250 Citations
  • 13 h-Index
  • 70 Article
  • 1 Letter
  • 1 Short survey

Optimization of Parameters for Quantitative Analysis of 123 I-Ioflupane SPECT Images for Monitoring Progression of Parkinson Disease

Kuo, P. H., Eshghi, N., Tinaz, S., Blumenfeld, H., Louis, E. D. & Zubal, G., Mar 1 2019, In : Journal of nuclear medicine technology. 47, 1, p. 70-74 5 p.

Research output: Contribution to journal › Article

Corpus Striatum
Single-Photon Emission-Computed Tomography
Parkinson Disease
Putamen
Dopamine Plasma Membrane Transport Proteins

Sex-limited penetrance of lymphedema to females with CELSR1 haploinsufficiency: A second family

Erickson, R. P., Lai, L-W., Mustacich, D. J., Bernas, M. J., Kuo, P. H. & Witte, M. H., Jan 1 2019, (Accepted/In press) In : Clinical Genetics.

Research output: Contribution to journal › Article

Lymphangiectasis
Haploinsufficiency
Lymphedema
Penetrance
Lymphatic Abnormalities

The Use of Random Forests to Classify Amyloid Brain PET

Zukotynski, K., Gaudet, V., Kuo, P. H., Adamo, S., Goubran, M., Scott, C., Bocti, C., Borrie, M., Chertkow, H., Frayne, R., Hsiung, R., Laforce, R., Noseworthy, M. D., Prato, F. S., Sahlas, D. J., Smith, E. E., Sossi, V., Thiel, A., Soucy, J. P., Tardif, J. C. & 1 others, Black, S. E., Oct 1 2019, In : Clinical nuclear medicine. 44, 10, p. 784-788 5 p.

Research output: Contribution to journal › Article

Amyloid
Brain
Gyrus Cinguli
Confidence Intervals
Lacunar Stroke

18F-FDG PET/CT can predict development of thyroiditis due to immunotherapy for lung cancer

Eshghi, N., Garland, L. L., Nia, E., Betancourt, R., Krupinski, E. A. & Kuo, P. H., Sep 1 2018, In : Journal of Nuclear Medicine Technology. 46, 3, p. 260-264 5 p.

Research output: Contribution to journal › Article

Thyroiditis
Fluorodeoxyglucose F18
Immunotherapy
Lung Neoplasms
Hypothyroidism
4 Citations (Scopus)

18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab

Eshghi, N., Lundeen, T. F., Mackinnon, L., Avery, R. & Kuo, P. H., May 1 2018, In : Clinical Nuclear Medicine. 43, 5, p. e142-e144

Research output: Contribution to journal › Article

Merkel Cell Carcinoma
Fluorodeoxyglucose F18
Cell Death
Neoplasm Metastasis
Ligands